Chargement en cours...
Towards the Oral Treatment of Ileo-Colonic Inflammatory Bowel Disease with Infliximab Tablets: Development and Validation of the Production Process
Infliximab (IFX) is an intravenously administered monoclonal antibody antagonizing the effects of tumor necrosis factor-alpha (TNF) systemically and is efficacious in the treatment of inflammatory bowel disease (IBD). However, studies suggest that the anti-inflammatory effects result from local immu...
Enregistré dans:
| Publié dans: | Pharmaceutics |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6781063/ https://ncbi.nlm.nih.gov/pubmed/31450748 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics11090428 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|